Only in the crazy sector of metabolic medicines can 32% revenue growth be considered a disappointment. That’s how much Eli Lilly’s revenue grew in 2024, but it was still not as much as the company or ...

CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

The Rural Health Transformation Program (RHTP) is more than a funding bill: It’s a $50 billion lifeline for rural hospitals on the brink of collapse, and time is running out to be positioned for ...

Update: This case was resolved on Sunday evening via a settlement, so the trial never occurred. The attorneys representing Hernandez told MedCity News that he categorically denies the allegations.

A patient has died following treatment with Elevidys, the Sarepta Therapeutics product that is the only FDA-approved gene therapy for Duchenne muscular dystrophy, the company disclosed Tuesday. The ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

Eli Lilly showed a drug that goes after two metabolic targets to treat obesity can successfully shed weight and become a revenue-generating heavyweight. Other companies aspire to improve on the Lilly ...

This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding announcements in ...

Solera Health, a healthcare technology company, has raised $40 million in Series E financing to expand access to digital health support, the company announced on Tuesday. In addition, Interim CEO John ...

Amino acids play important roles in tumors, so targeting these molecules makes sense for cancer drug research. But much of this research has focused on just one of the 20 amino acids found in humans.

A rare liver disease that can progress to organ failure now has a new FDA-approved therapy, a drug from Ipsen that brings a novel approach to treating the chronic condition. The Ipsen drug, ...